miR-10b |
Promotes cell migration, invasion and metastasis |
TP53, PAX6, NOTCH1, HOXD10 |
[11, 12] |
miR-19a/b |
Promotes gastric cancer cell migration, invasion and metastasis |
MXD1 |
[13] |
miR-135b |
Promotes cell migration, invasion and metastasis |
LATS2, β-TrCP, NDR2, LZTS1 |
[14] |
miR-362-5p |
Promotes cell proliferation, migration and invasion in vitro and tumor growth and metastasis in vivo
|
CYLD |
[15] |
miR-34a |
Inhibits cell migration, invasion and lung metastasis of breast cancer cells; suppresses prostate CSCs and metastasis; decreases the production of the chemokine CCL22; disturbs the bone metastatic niche |
Fra-1, CD44, CCL22, Tgif2 |
[16, 68, 72, 73] |
miR-34c |
Inhibits cell migration, invasion and lung metastasis of breast cancer cells |
Fra-1 |
[16] |
miR-135a |
Inhibits prostate cancer cell migration and invasion |
ROCK1, ROCK2 |
[17] |
miR-137 |
Reduces the invasiveness of colorectal cancer cells |
FMNL2 |
[18] |
miR-145 |
Attenuates gastric cancer cell migratory and invasive abilities in vitro and suppresses the metastatic cascade in vivo; inhibits the invasion and metastasis of neuroblastoma cells |
N-cadherin, HIF-2α |
[19, 20] |
miR-1 |
Affects the cellular organization of F-actin and impairs tumor cell invasion and filopodia formation |
FN1, LASP1, XPO6 |
[21] |
miR-335 |
Suppresses cell migration, invasion and metastasis |
Tenascin C, SOX4 |
[24] |
miR-29c |
Inhibits tumor invasion and metastasis |
Collagens, Laminin γ1 |
[25] |
miR-21 |
Promotes epithelial collective cell migration, invasion and lung metastasis; enhances colorectal cancer cell intravasation |
TPM1, PDCD4, Maspin, PDCD4 |
[27, 30, 31] |
miR-124 |
Modulates the intercellular adhesion of leading cells; inhibits EMT in vitro and suppresses intrahepatic and pulmonary metastasis in vivo
|
Integrin β1, ROCK2, EZH2 |
[28, 55] |
miR-105 |
Destroys the integrity of vascular endothelial barriers to promote metastasis |
ZO-1 |
[29] |
miR-182 |
Promotes cancer cell intravasation into the circulation |
Mtss1, Pai1, Rsu1, Timp1 |
[32] |
miR-520c/373 |
Inhibits cell invasion in vitro and the intravasation of breast cancer cells in vivo
|
RELA, TGFBR2 |
[33] |
let-7 |
Inhibits bone metastasis of breast cancer cells |
HMGA2, Snail |
[34] |
miR-296-3p |
Promotes prostate cancer cell survival |
ICAM-1 |
[35] |
miR-148b |
Inhibits multiple steps of tumor progression via the regulation of invasion, resistance to anoikis, extravasation, lung metastasis colonization and chemotherapeutic response |
ITGA5, ROCK1, PIK3CA/p110α, NRAS, CSF1 |
[36] |
miR-155 |
Negatively regulates the function of the brain endothelial barrier; promotes TGF-β-induced EMT, tight junction dissolution, cell migration and invasion. Suppresses tumor growth via the regulation of the tumor microenvironment |
Annexin-2, Claudin-1, DOCK-1, Syntenin-1, c-Maf, Pu.1, Ship1, C/EBPβ, HIF-1α |
[38, 50, 76–78] |
miR-214 |
Suppresses cell migration and invasion in vitro and inhibits liver metastasis of colorectal cancer cells in vivo but promotes migration, invasion and resistance to anoikis of melanoma cells in vitro and the extravasation and lung metastasis formation in vivo
|
FGFR1, TFAP2C |
[39–41] |
miR-31 |
Represses local invasion, extravasation and initial survival in distant tissues and distant metastatic colonization |
ITGA5, RDX, RhoA |
[42] |
miR-25 |
Inhibits extravasation of prostate cancer cells in vivo
|
αv- and α6-integrins |
[43] |
miR-200s |
Inhibits EMT but promotes metastatic colonization |
Sec23a, ZEB1, ZEB2 |
[44, 52, 53] |
miR-122 |
Promotes metastatic colonization of breast cancer cells |
PKM2 |
[45] |
miR-149 |
Inhibits basal-like breast cancer cell migration and invasion in vitro and impairs lung colonization in vivo
|
Rap1a, Rap1b |
[46] |
miR-493 |
Inhibits the settlement of metastasized colon cancer cells in the liver; promotes the death of colon cancer cells |
IGF1R |
[47] |
miR-148a |
Inhibits hepatoma cell migration in vitro and pulmonary metastatic colonization in vivo
|
Met |
[48] |
miR-9 |
Promotes breast cancer cell motility and invasiveness; enhances squamous cell carcinoma CSC expansion and metastasis |
CDH1, α-catenin |
[49, 66] |
miR-20a |
Induces EMT and promotes metastasis |
Smad7 |
[51] |
miR-203 |
Suppresses cell invasion and EMT in vitro and lung metastatic colonization in vivo
|
SNAI2 |
[54] |
miR-612 |
Inhibits local invasion and distant metastatic colonization |
Akt2 |
[56] |
miR-125a |
Inhibits EMT of ovarian cancer cells |
ARID3B |
[58] |
miR-424 |
Promotes EMT |
TGFBR3 |
[60] |
miR-22 |
Promotes EMT, invasiveness, stemness and metastasis |
TET1, TET2, TET3 |
[64] |
miR-199a |
Endows breast cancer cells with enhanced CSC properties; promotes invasion, angiogenesis and colonization in the case of melanoma |
FOXP2, ApoE |
[65, 92] |
miR-133a |
Promotes invasion of CSCs that express high levels of CD133 |
SGMS2, UBA2, SNX30, ANXA2 |
[67] |
miR-7 |
Suppresses cell invasion and metastasis; inhibits the ability of breast CSCs to metastasize to the brain |
SETDB1, KLF4 |
[69, 70] |
miR-33b |
Inhibits the stemness and lung metastasis of breast cancer cells |
HMGA2, SALL4, Twist1 |
[71] |
miR-494 |
Promotes the accumulation of MDSCs in tumor tissues |
PTEN |
[81] |
miR-101 |
Augments cancer cell stemness and enhances the tumorigenic and metastatic potential of cancer cells; inhibits HCC growth, intrahepatic metastasis and distant metastasis |
CtBP2, ROCK2 |
[82, 94] |
miR-126 |
Inhibits endothelial recruitment, metastatic angiogenesis and metastatic colonization at distant sites |
IGFBP2, PITPNC1, MERTK, SDF-1α |
[83, 84] |
miR-126* |
Suppresses breast cancer metastasis via the inhibition of the recruitment of mesenchymal stem cells and inflammatory monocytes |
SDF-1α |
[84] |
miR-23b |
Promotes breast cancer cell dormancy in a metastatic niche |
MARCKS |
[87] |
miR-127/197/222/223 |
Promotes breast cancer cell quiescence |
CXCL12 |
[88] |
miR-103/107 |
Promotes local invasion and liver metastasis |
DAPK, KLF4 |
[89] |